<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on a 62 year-old woman who developed a severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> requiring frequent packed red cell and platelet transfusions </plain></SENT>
<SENT sid="1" pm="."><plain>Since conventional pharmacological therapy was ineffective, treatment with <z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> was started, resulting in a significant increase of leukocyte, platelet, and red cell counts </plain></SENT>
<SENT sid="2" pm="."><plain>However, 5 months after the beginning of <z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> treatment, despite a past medical history not significant for clinical <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e>, the patient developed tubercular <z:hpo ids='HP_0001701'>pericarditis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This report underlines the need for a careful follow-up of <z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi>-treated patients aimed at a prompt diagnosis of possible infectious complications </plain></SENT>
</text></document>